BMXXY OTC
bioMérieux S.A.
1W: -3.1%
1M: +0.8%
3M: +20.1%
YTD: -28.2%
1Y: -38.2%
3Y: -3.3%
$9.04
-0.08 (-0.87%)
Weekly Expected Move ±5.1%
$8
$9
$9
$10
$10
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$3.9B
-1.8% ▼
5Y CAGR: +4.6%
Gross Profit
$2.1B
-7.1% ▼
5Y CAGR: +3.5%
Operating Income
$539M
-8.4% ▼
5Y CAGR: -0.4%
Net Income
$382M
-11.7% ▼
5Y CAGR: -1.1%
EPS (Diluted)
$0.32
-11.3% ▼
5Y CAGR: -1.2%
EBITDA
$960M
+7.0% ▲
5Y CAGR: +3.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.6B | $3.7B | $4.0B | $3.9B |
| YoY Growth | +8.3% | +6.3% | +2.4% | +8.3% | -1.8% |
| Cost of Revenue | $1.4B | $1.6B | $1.6B | $1.8B | $1.9B |
| Gross Profit | $2.0B | $2.0B | $2.1B | $2.2B | $2.1B |
| Gross Margin | 58.3% | 54.6% | 56.0% | 55.7% | 52.6% |
| R&D Expenses | $386M | $447M | $540M | $492M | $487M |
| SG&A Expenses | $816M | $955M | $1.0B | $1.1B | $1.1B |
| Operating Expenses | $1.2B | $1.4B | $1.6B | $1.6B | $1.5B |
| Operating Income | $784M | $587M | $439M | $589M | $539M |
| Operating Margin | 23.2% | 16.4% | 11.9% | 14.8% | 13.8% |
| Interest Expense | $9M | $4M | $4M | $16M | $0 |
| Income Before Tax | $774M | $580M | $437M | $579M | $505M |
| Tax Expense | $176M | $140M | $114M | $154M | $124M |
| Net Income | $601M | $452M | $358M | $432M | $382M |
| Net Margin | 17.8% | 12.6% | 9.7% | 10.9% | 9.8% |
| EPS (Diluted) | $0.51 | $0.38 | $0.30 | $0.36 | $0.32 |
| EBITDA | $1.0B | $853M | $858M | $898M | $960M |
| Shares Outstanding | 1.19B | 1.18B | 1.19B | 1.19B | 1.19B |